Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juergen Braun

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|February 12, 2025
Why the term nr-axSpA should not be used for diagnosisJuergen Braun
Clinical and Experimental Rheumatology|October 20, 2012
Axial spondyloarthritis: thoughts about nomenclature and treatment targetsJuergen Braun
Annals of the Rheumatic Diseases|February 3, 2023
Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"Juergen Braun
Rheumatology (Oxford, England)|November 19, 2016
New targets in psoriatic arthritisJuergen Braun
RMD Open|December 14, 2022
Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint?Juergen Braun
Rheumatology (Oxford, England)|July 20, 2019
Using combinations of biomarkers to understand inflammation and bone formation in axial spondyloarthritis - is anything better than CRP?Juergen Braun
Arthritis Research|September 12, 2002
Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approachesJuergen Braun, Joachim Sieper
Rheumatology (Oxford, England)|December 19, 2018
Active and chronic sacroiliitis, spondylitis and enthesitis, How specific are imaging findings for axial spondyloarthritis?Juergen Braun, Xenofon Baraliakos
Current Opinion in Rheumatology|April 18, 2009
An update on methotrexateJuergen Braun, Rolf Rau
Rheumatology (Oxford, England)|September 17, 2009
Hip involvement in ankylosing spondylitis: what is the verdict?Xenofon Baraliakos, Juergen Braun
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|February 12, 2025
Why the term nr-axSpA should not be used for diagnosisJuergen Braun
Clinical and Experimental Rheumatology|October 20, 2012
Axial spondyloarthritis: thoughts about nomenclature and treatment targetsJuergen Braun
Annals of the Rheumatic Diseases|February 3, 2023
Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"Juergen Braun
Rheumatology (Oxford, England)|November 19, 2016
New targets in psoriatic arthritisJuergen Braun
RMD Open|December 14, 2022
Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint?Juergen Braun
Rheumatology (Oxford, England)|July 20, 2019
Using combinations of biomarkers to understand inflammation and bone formation in axial spondyloarthritis - is anything better than CRP?Juergen Braun
Arthritis Research|September 12, 2002
Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approachesJuergen Braun, Joachim Sieper
Rheumatology (Oxford, England)|December 19, 2018
Active and chronic sacroiliitis, spondylitis and enthesitis, How specific are imaging findings for axial spondyloarthritis?Juergen Braun, Xenofon Baraliakos
Current Opinion in Rheumatology|April 18, 2009
An update on methotrexateJuergen Braun, Rolf Rau
Rheumatology (Oxford, England)|September 17, 2009
Hip involvement in ankylosing spondylitis: what is the verdict?Xenofon Baraliakos, Juergen Braun
Pageof 15